Cite
HARVARD Citation
Clark, J. et al. (2021). Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. Journal of investigative medicine. pp. 888-892. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Clark, J. et al. (2021). Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. Journal of investigative medicine. pp. 888-892. [Online].